Detail Information of Epigenetic Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0372 Transporter Info | ||||
Gene Name | SLC46A1 | ||||
Transporter Name | Proton-coupled folate transporter | ||||
Gene ID | |||||
UniProt ID | |||||
Epigenetic Regulations of This DT (EGR) | |||||
---|---|---|---|---|---|
Methylation |
|||||
Leukemia |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Hypermethylation of SLC46A1 in leukemia | [ 1 ] | |||
Location |
Promoter | ||||
Epigenetic Type |
Methylation | Experiment Method | Bisulfite sequencing | ||
Related Molecular Changes |
Down regulation of SLC46A1 | Experiment Method | RT-qPCR | ||
Studied Phenotype |
Leukemia [ ICD-11: 2B33] | ||||
Experimental Material |
Multiple cell lines of human | ||||
Additional Notes |
SLC46A1 had increased methylation and decreased expression in pancreatic cancer. | ||||
Mesothelioma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Hypermethylation of SLC46A1 in mesothelioma | [ 2 ] | |||
Location |
Promoter (-309 to 104 bp) | ||||
Epigenetic Type |
Methylation | Experiment Method | Bisulfite sequencing | ||
Related Molecular Changes |
Down regulation of SLC46A1 | Experiment Method | RT-qPCR | ||
Studied Phenotype |
Mesothelioma [ ICD-11: 2C26] | ||||
Experimental Material |
Multiple cell lines of human | ||||
Additional Notes |
Modulation of promoter methylation by 5-aza-2'-deoxycytidine may eradicate antifolate-resistant tumor cells displaying low SLC46A1 levels. | ||||
Cervical cancer |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Hypomethylation of SLC46A1 in cervical cancer (compare with antifolate-resistant counterpart cells) | [ 3 ] | |||
Location |
Promoter | ||||
Epigenetic Type |
Methylation | Experiment Method | Bisulfite sequencing | ||
Related Molecular Changes |
Down regulation of SLC46A1 | Experiment Method | RT-qPCR | ||
Studied Phenotype |
Cervical cancer [ ICD-11: 2C77.Z] | ||||
Experimental Material |
Human cervical carcinoma cell line (Hela) | ||||
Additional Notes |
Hypermethylation of the human proton-coupled folate transporter (SLC46A1) minimal transcriptional regulatory region in an antifolate-resistant HeLa cell line. | ||||
Prostate cancer |
7 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC46A1 in prostate cancer | [ 4 ] | |||
Location |
5'UTR (cg13765368) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 3.93E+00 | Statistic Test | p-value: 1.40E-02; Z-score: 1.17E+01 | ||
Methylation in Case |
3.02E-01 (Median) | Methylation in Control | 7.69E-02 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC46A1 in prostate cancer | [ 4 ] | |||
Location |
TSS1500 (cg23531340) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.08E+00 | Statistic Test | p-value: 3.43E-02; Z-score: 1.48E+00 | ||
Methylation in Case |
9.05E-01 (Median) | Methylation in Control | 8.40E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC46A1 in prostate cancer | [ 4 ] | |||
Location |
Body (cg26954464) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.21E+00 | Statistic Test | p-value: 2.29E-03; Z-score: 3.19E+00 | ||
Methylation in Case |
9.09E-01 (Median) | Methylation in Control | 7.52E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC46A1 in prostate cancer | [ 4 ] | |||
Location |
Body (cg02349468) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.68E+00 | Statistic Test | p-value: 3.84E-03; Z-score: -2.94E+00 | ||
Methylation in Case |
3.56E-01 (Median) | Methylation in Control | 5.99E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC46A1 in prostate cancer | [ 4 ] | |||
Location |
Body (cg12589308) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.05E+00 | Statistic Test | p-value: 1.12E-02; Z-score: 2.54E+00 | ||
Methylation in Case |
9.50E-01 (Median) | Methylation in Control | 9.01E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC46A1 in prostate cancer | [ 4 ] | |||
Location |
Body (cg11017086) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.62E+00 | Statistic Test | p-value: 3.96E-02; Z-score: -2.48E+00 | ||
Methylation in Case |
2.41E-01 (Median) | Methylation in Control | 3.91E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC46A1 in prostate cancer | [ 4 ] | |||
Location |
3'UTR (cg15090262) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.05E+00 | Statistic Test | p-value: 3.27E-03; Z-score: 3.53E+00 | ||
Methylation in Case |
9.06E-01 (Median) | Methylation in Control | 8.66E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Bladder cancer |
6 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC46A1 in bladder cancer | [ 5 ] | |||
Location |
TSS1500 (cg27176697) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.67E+00 | Statistic Test | p-value: 9.04E-07; Z-score: -6.18E+00 | ||
Methylation in Case |
4.95E-01 (Median) | Methylation in Control | 8.27E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC46A1 in bladder cancer | [ 5 ] | |||
Location |
TSS1500 (cg02062123) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.49E+00 | Statistic Test | p-value: 4.32E-05; Z-score: -3.85E+00 | ||
Methylation in Case |
1.67E-01 (Median) | Methylation in Control | 2.49E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC46A1 in bladder cancer | [ 5 ] | |||
Location |
TSS1500 (cg22436928) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.38E+00 | Statistic Test | p-value: 3.53E-02; Z-score: -1.68E+00 | ||
Methylation in Case |
6.58E-02 (Median) | Methylation in Control | 9.08E-02 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC46A1 in bladder cancer | [ 5 ] | |||
Location |
TSS200 (cg23873654) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.97E+00 | Statistic Test | p-value: 3.30E-02; Z-score: -1.96E+00 | ||
Methylation in Case |
1.35E-02 (Median) | Methylation in Control | 2.67E-02 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC46A1 in bladder cancer | [ 5 ] | |||
Location |
Body (cg19822764) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.20E+00 | Statistic Test | p-value: 2.37E-02; Z-score: -3.10E+00 | ||
Methylation in Case |
4.64E-01 (Median) | Methylation in Control | 5.59E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC46A1 in bladder cancer | [ 5 ] | |||
Location |
Body (cg10762038) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.00E+00 | Statistic Test | p-value: 4.65E-02; Z-score: -2.21E-01 | ||
Methylation in Case |
7.40E-01 (Median) | Methylation in Control | 7.43E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Breast cancer |
8 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC46A1 in breast cancer | [ 6 ] | |||
Location |
TSS1500 (cg27176697) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.08E+00 | Statistic Test | p-value: 1.36E-13; Z-score: 1.56E+00 | ||
Methylation in Case |
8.90E-01 (Median) | Methylation in Control | 8.23E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC46A1 in breast cancer | [ 6 ] | |||
Location |
TSS1500 (cg02062123) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.38E+00 | Statistic Test | p-value: 2.81E-09; Z-score: 3.04E+00 | ||
Methylation in Case |
2.86E-01 (Median) | Methylation in Control | 2.07E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC46A1 in breast cancer | [ 6 ] | |||
Location |
Body (cg21732844) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.56E+00 | Statistic Test | p-value: 3.38E-27; Z-score: 5.59E+00 | ||
Methylation in Case |
6.33E-01 (Median) | Methylation in Control | 4.06E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC46A1 in breast cancer | [ 6 ] | |||
Location |
Body (cg04010423) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.64E+00 | Statistic Test | p-value: 7.23E-22; Z-score: 4.75E+00 | ||
Methylation in Case |
5.26E-01 (Median) | Methylation in Control | 3.20E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC46A1 in breast cancer | [ 6 ] | |||
Location |
Body (cg11351837) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.44E+00 | Statistic Test | p-value: 2.95E-20; Z-score: 3.54E+00 | ||
Methylation in Case |
6.29E-01 (Median) | Methylation in Control | 4.36E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC46A1 in breast cancer | [ 6 ] | |||
Location |
Body (cg19822764) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.38E+00 | Statistic Test | p-value: 1.10E-12; Z-score: 2.43E+00 | ||
Methylation in Case |
6.19E-01 (Median) | Methylation in Control | 4.50E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC46A1 in breast cancer | [ 6 ] | |||
Location |
Body (cg25910803) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.35E+00 | Statistic Test | p-value: 8.75E-09; Z-score: 1.19E+00 | ||
Methylation in Case |
5.06E-01 (Median) | Methylation in Control | 3.75E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC46A1 in breast cancer | [ 6 ] | |||
Location |
Body (cg10762038) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.05E+00 | Statistic Test | p-value: 2.84E-03; Z-score: -9.68E-01 | ||
Methylation in Case |
7.03E-01 (Median) | Methylation in Control | 7.39E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Renal cell carcinoma |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC46A1 in clear cell renal cell carcinoma | [ 7 ] | |||
Location |
TSS1500 (cg22436928) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.26E+00 | Statistic Test | p-value: 1.50E-02; Z-score: 7.02E-01 | ||
Methylation in Case |
4.35E-02 (Median) | Methylation in Control | 3.45E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC46A1 in clear cell renal cell carcinoma | [ 7 ] | |||
Location |
TSS200 (cg23873654) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.09E+00 | Statistic Test | p-value: 2.74E-04; Z-score: 6.91E-01 | ||
Methylation in Case |
1.60E-02 (Median) | Methylation in Control | 1.47E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC46A1 in clear cell renal cell carcinoma | [ 7 ] | |||
Location |
TSS200 (cg10405239) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.14E+00 | Statistic Test | p-value: 4.10E-03; Z-score: 4.79E-01 | ||
Methylation in Case |
2.43E-02 (Median) | Methylation in Control | 2.12E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC46A1 in clear cell renal cell carcinoma | [ 7 ] | |||
Location |
Body (cg25910803) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.10E+00 | Statistic Test | p-value: 2.55E-02; Z-score: 1.29E+00 | ||
Methylation in Case |
5.42E-01 (Median) | Methylation in Control | 4.92E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Hepatocellular carcinoma |
15 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC46A1 in hepatocellular carcinoma | [ 8 ] | |||
Location |
TSS1500 (cg02062123) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.06E+00 | Statistic Test | p-value: 3.56E-02; Z-score: 4.28E-01 | ||
Methylation in Case |
2.39E-01 (Median) | Methylation in Control | 2.24E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC46A1 in hepatocellular carcinoma | [ 8 ] | |||
Location |
TSS200 (cg10405239) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.07E+00 | Statistic Test | p-value: 1.70E-02; Z-score: -3.72E-01 | ||
Methylation in Case |
6.41E-02 (Median) | Methylation in Control | 6.84E-02 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC46A1 in hepatocellular carcinoma | [ 8 ] | |||
Location |
1stExon (cg15612845) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.13E+00 | Statistic Test | p-value: 2.64E-02; Z-score: -4.75E-01 | ||
Methylation in Case |
3.44E-02 (Median) | Methylation in Control | 3.91E-02 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC46A1 in hepatocellular carcinoma | [ 8 ] | |||
Location |
Body (cg20818262) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.74E+00 | Statistic Test | p-value: 2.59E-22; Z-score: -5.97E+00 | ||
Methylation in Case |
4.35E-01 (Median) | Methylation in Control | 7.58E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC46A1 in hepatocellular carcinoma | [ 8 ] | |||
Location |
Body (cg17343107) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.65E+00 | Statistic Test | p-value: 2.96E-17; Z-score: -3.42E+00 | ||
Methylation in Case |
3.24E-01 (Median) | Methylation in Control | 5.35E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC46A1 in hepatocellular carcinoma | [ 8 ] | |||
Location |
Body (cg24585559) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.31E+00 | Statistic Test | p-value: 5.53E-13; Z-score: -4.00E+00 | ||
Methylation in Case |
6.36E-01 (Median) | Methylation in Control | 8.31E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC46A1 in hepatocellular carcinoma | [ 8 ] | |||
Location |
Body (cg08535112) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.62E+00 | Statistic Test | p-value: 4.05E-10; Z-score: -1.88E+00 | ||
Methylation in Case |
3.96E-01 (Median) | Methylation in Control | 6.43E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC46A1 in hepatocellular carcinoma | [ 8 ] | |||
Location |
Body (cg09075844) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.30E+00 | Statistic Test | p-value: 1.01E-09; Z-score: -1.80E+00 | ||
Methylation in Case |
3.64E-01 (Median) | Methylation in Control | 4.74E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC46A1 in hepatocellular carcinoma | [ 8 ] | |||
Location |
Body (cg21732844) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.20E+00 | Statistic Test | p-value: 1.36E-07; Z-score: -1.25E+00 | ||
Methylation in Case |
3.92E-01 (Median) | Methylation in Control | 4.70E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Methylation of SLC46A1 in hepatocellular carcinoma | [ 8 ] | |||
Location |
Body (cg04010423) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.26E+00 | Statistic Test | p-value: 1.74E-07; Z-score: -1.41E+00 | ||
Methylation in Case |
3.35E-01 (Median) | Methylation in Control | 4.23E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 11 |
Methylation of SLC46A1 in hepatocellular carcinoma | [ 8 ] | |||
Location |
Body (cg19822764) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.20E+00 | Statistic Test | p-value: 3.17E-07; Z-score: -1.33E+00 | ||
Methylation in Case |
4.78E-01 (Median) | Methylation in Control | 5.71E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 12 |
Methylation of SLC46A1 in hepatocellular carcinoma | [ 8 ] | |||
Location |
Body (cg11351837) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.21E+00 | Statistic Test | p-value: 5.08E-07; Z-score: -1.52E+00 | ||
Methylation in Case |
4.10E-01 (Median) | Methylation in Control | 4.98E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 13 |
Methylation of SLC46A1 in hepatocellular carcinoma | [ 8 ] | |||
Location |
Body (cg25910803) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.18E+00 | Statistic Test | p-value: 1.61E-06; Z-score: -1.02E+00 | ||
Methylation in Case |
3.85E-01 (Median) | Methylation in Control | 4.55E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 14 |
Methylation of SLC46A1 in hepatocellular carcinoma | [ 8 ] | |||
Location |
Body (cg10762038) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.06E+00 | Statistic Test | p-value: 7.14E-05; Z-score: 1.26E+00 | ||
Methylation in Case |
7.56E-01 (Median) | Methylation in Control | 7.14E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 15 |
Methylation of SLC46A1 in hepatocellular carcinoma | [ 8 ] | |||
Location |
3'UTR (cg05749559) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.44E+00 | Statistic Test | p-value: 3.82E-14; Z-score: -3.90E+00 | ||
Methylation in Case |
4.41E-01 (Median) | Methylation in Control | 6.33E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
HIV infection |
9 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC46A1 in HIV infection | [ 9 ] | |||
Location |
TSS1500 (cg02062123) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.19E+00 | Statistic Test | p-value: 1.47E-04; Z-score: 1.21E+00 | ||
Methylation in Case |
3.05E-01 (Median) | Methylation in Control | 2.57E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC46A1 in HIV infection | [ 9 ] | |||
Location |
TSS1500 (cg22436928) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.22E+00 | Statistic Test | p-value: 4.22E-03; Z-score: 1.17E+00 | ||
Methylation in Case |
1.17E-01 (Median) | Methylation in Control | 9.58E-02 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC46A1 in HIV infection | [ 9 ] | |||
Location |
TSS200 (cg23873654) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.72E+00 | Statistic Test | p-value: 2.32E-03; Z-score: 9.52E-01 | ||
Methylation in Case |
1.51E-02 (Median) | Methylation in Control | 8.78E-03 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC46A1 in HIV infection | [ 9 ] | |||
Location |
TSS200 (cg10405239) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.20E+00 | Statistic Test | p-value: 3.34E-02; Z-score: 9.24E-01 | ||
Methylation in Case |
7.14E-02 (Median) | Methylation in Control | 5.94E-02 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC46A1 in HIV infection | [ 9 ] | |||
Location |
Body (cg10762038) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.04E+00 | Statistic Test | p-value: 1.25E-06; Z-score: -1.21E+00 | ||
Methylation in Case |
8.01E-01 (Median) | Methylation in Control | 8.35E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC46A1 in HIV infection | [ 9 ] | |||
Location |
Body (cg21732844) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.01E+00 | Statistic Test | p-value: 6.02E-03; Z-score: 3.99E-01 | ||
Methylation in Case |
9.19E-01 (Median) | Methylation in Control | 9.12E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC46A1 in HIV infection | [ 9 ] | |||
Location |
Body (cg19822764) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.01E+00 | Statistic Test | p-value: 6.40E-03; Z-score: 8.64E-01 | ||
Methylation in Case |
9.36E-01 (Median) | Methylation in Control | 9.26E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC46A1 in HIV infection | [ 9 ] | |||
Location |
Body (cg04010423) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.03E+00 | Statistic Test | p-value: 7.16E-03; Z-score: 7.82E-01 | ||
Methylation in Case |
8.71E-01 (Median) | Methylation in Control | 8.46E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC46A1 in HIV infection | [ 9 ] | |||
Location |
Body (cg25910803) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.00E+00 | Statistic Test | p-value: 2.76E-02; Z-score: 1.32E-01 | ||
Methylation in Case |
8.91E-01 (Median) | Methylation in Control | 8.89E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Lung adenocarcinoma |
6 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC46A1 in lung adenocarcinoma | [ 10 ] | |||
Location |
TSS1500 (cg02062123) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.15E+00 | Statistic Test | p-value: 4.30E-02; Z-score: 1.14E+00 | ||
Methylation in Case |
3.73E-01 (Median) | Methylation in Control | 3.25E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC46A1 in lung adenocarcinoma | [ 10 ] | |||
Location |
1stExon (cg15612845) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.20E+00 | Statistic Test | p-value: 4.76E-02; Z-score: -8.26E-01 | ||
Methylation in Case |
5.02E-02 (Median) | Methylation in Control | 6.01E-02 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC46A1 in lung adenocarcinoma | [ 10 ] | |||
Location |
Body (cg11351837) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.13E+00 | Statistic Test | p-value: 1.67E-03; Z-score: 1.86E+00 | ||
Methylation in Case |
8.11E-01 (Median) | Methylation in Control | 7.18E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC46A1 in lung adenocarcinoma | [ 10 ] | |||
Location |
Body (cg04010423) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.14E+00 | Statistic Test | p-value: 5.58E-03; Z-score: 1.76E+00 | ||
Methylation in Case |
7.07E-01 (Median) | Methylation in Control | 6.18E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC46A1 in lung adenocarcinoma | [ 10 ] | |||
Location |
Body (cg25910803) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.11E+00 | Statistic Test | p-value: 1.42E-02; Z-score: 1.49E+00 | ||
Methylation in Case |
7.57E-01 (Median) | Methylation in Control | 6.81E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC46A1 in lung adenocarcinoma | [ 10 ] | |||
Location |
Body (cg19822764) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.07E+00 | Statistic Test | p-value: 2.00E-02; Z-score: 1.68E+00 | ||
Methylation in Case |
8.19E-01 (Median) | Methylation in Control | 7.66E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Pancretic ductal adenocarcinoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC46A1 in pancretic ductal adenocarcinoma | [ 11 ] | |||
Location |
TSS1500 (cg11754206) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.05E+00 | Statistic Test | p-value: 3.62E-04; Z-score: 4.29E-01 | ||
Methylation in Case |
3.26E-01 (Median) | Methylation in Control | 3.11E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Panic disorder |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC46A1 in panic disorder | [ 12 ] | |||
Location |
TSS1500 (cg22436928) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -9.33E-01 | Statistic Test | p-value: 1.66E-02; Z-score: -5.47E-01 | ||
Methylation in Case |
-4.22E+00 (Median) | Methylation in Control | -3.93E+00 (Median) | ||
Studied Phenotype |
Panic disorder [ ICD-11: 6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC46A1 in panic disorder | [ 12 ] | |||
Location |
Body (cg21732844) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.03E+00 | Statistic Test | p-value: 3.04E-02; Z-score: 1.56E-01 | ||
Methylation in Case |
3.05E+00 (Median) | Methylation in Control | 2.97E+00 (Median) | ||
Studied Phenotype |
Panic disorder [ ICD-11: 6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Papillary thyroid cancer |
9 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC46A1 in papillary thyroid cancer | [ 13 ] | |||
Location |
TSS1500 (cg22436928) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.07E+00 | Statistic Test | p-value: 4.86E-02; Z-score: -3.12E-01 | ||
Methylation in Case |
7.04E-02 (Median) | Methylation in Control | 7.51E-02 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC46A1 in papillary thyroid cancer | [ 13 ] | |||
Location |
TSS200 (cg10405239) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.08E+00 | Statistic Test | p-value: 4.22E-03; Z-score: 6.22E-01 | ||
Methylation in Case |
5.09E-02 (Median) | Methylation in Control | 4.70E-02 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC46A1 in papillary thyroid cancer | [ 13 ] | |||
Location |
TSS200 (cg10923085) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.11E+00 | Statistic Test | p-value: 5.17E-03; Z-score: -6.52E-01 | ||
Methylation in Case |
5.33E-02 (Median) | Methylation in Control | 5.90E-02 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC46A1 in papillary thyroid cancer | [ 13 ] | |||
Location |
1stExon (cg00497630) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.03E+00 | Statistic Test | p-value: 2.57E-02; Z-score: 2.84E-01 | ||
Methylation in Case |
8.74E-02 (Median) | Methylation in Control | 8.49E-02 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC46A1 in papillary thyroid cancer | [ 13 ] | |||
Location |
Body (cg25910803) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.12E+00 | Statistic Test | p-value: 2.08E-06; Z-score: 1.66E+00 | ||
Methylation in Case |
6.10E-01 (Median) | Methylation in Control | 5.43E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC46A1 in papillary thyroid cancer | [ 13 ] | |||
Location |
Body (cg10762038) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 3.63E-03; Z-score: -6.57E-01 | ||
Methylation in Case |
8.36E-01 (Median) | Methylation in Control | 8.56E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC46A1 in papillary thyroid cancer | [ 13 ] | |||
Location |
Body (cg04010423) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.08E+00 | Statistic Test | p-value: 8.12E-03; Z-score: 6.67E-01 | ||
Methylation in Case |
5.60E-01 (Median) | Methylation in Control | 5.18E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC46A1 in papillary thyroid cancer | [ 13 ] | |||
Location |
Body (cg21732977) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.07E+00 | Statistic Test | p-value: 8.54E-03; Z-score: -6.51E-01 | ||
Methylation in Case |
8.00E-02 (Median) | Methylation in Control | 8.55E-02 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC46A1 in papillary thyroid cancer | [ 13 ] | |||
Location |
Body (cg11351837) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.07E+00 | Statistic Test | p-value: 1.98E-02; Z-score: 9.28E-01 | ||
Methylation in Case |
6.75E-01 (Median) | Methylation in Control | 6.28E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Colon cancer |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC46A1 in colon adenocarcinoma | [ 14 ] | |||
Location |
TSS200 (cg26763542) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.06E+00 | Statistic Test | p-value: 3.62E-03; Z-score: -1.49E+00 | ||
Methylation in Case |
6.97E-01 (Median) | Methylation in Control | 7.38E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC46A1 in colon adenocarcinoma | [ 14 ] | |||
Location |
Body (cg07601645) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.10E+00 | Statistic Test | p-value: 7.08E-05; Z-score: 1.53E+00 | ||
Methylation in Case |
6.77E-01 (Median) | Methylation in Control | 6.15E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC46A1 in colon adenocarcinoma | [ 14 ] | |||
Location |
Body (cg13617811) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.47E+00 | Statistic Test | p-value: 6.64E-04; Z-score: -1.94E+00 | ||
Methylation in Case |
2.56E-01 (Median) | Methylation in Control | 3.76E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC46A1 in colon adenocarcinoma | [ 14 ] | |||
Location |
Body (cg08094571) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.13E+00 | Statistic Test | p-value: 2.21E-03; Z-score: -1.67E+00 | ||
Methylation in Case |
3.37E-01 (Median) | Methylation in Control | 3.80E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Colorectal cancer |
8 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC46A1 in colorectal cancer | [ 15 ] | |||
Location |
TSS200 (cg10405239) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.08E+00 | Statistic Test | p-value: 1.81E-03; Z-score: 7.33E-01 | ||
Methylation in Case |
9.52E-02 (Median) | Methylation in Control | 8.79E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC46A1 in colorectal cancer | [ 15 ] | |||
Location |
1stExon (cg00497630) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.13E+00 | Statistic Test | p-value: 4.67E-03; Z-score: 9.50E-01 | ||
Methylation in Case |
1.10E-01 (Median) | Methylation in Control | 9.76E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC46A1 in colorectal cancer | [ 15 ] | |||
Location |
1stExon (cg15612845) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.02E+00 | Statistic Test | p-value: 3.07E-02; Z-score: 1.19E-01 | ||
Methylation in Case |
2.36E-02 (Median) | Methylation in Control | 2.31E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC46A1 in colorectal cancer | [ 15 ] | |||
Location |
Body (cg25910803) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.43E+00 | Statistic Test | p-value: 3.25E-10; Z-score: 2.61E+00 | ||
Methylation in Case |
7.14E-01 (Median) | Methylation in Control | 5.01E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC46A1 in colorectal cancer | [ 15 ] | |||
Location |
Body (cg19822764) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.26E+00 | Statistic Test | p-value: 7.22E-07; Z-score: 1.63E+00 | ||
Methylation in Case |
7.64E-01 (Median) | Methylation in Control | 6.06E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC46A1 in colorectal cancer | [ 15 ] | |||
Location |
Body (cg21732844) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.12E+00 | Statistic Test | p-value: 2.70E-05; Z-score: 1.44E+00 | ||
Methylation in Case |
8.55E-01 (Median) | Methylation in Control | 7.61E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC46A1 in colorectal cancer | [ 15 ] | |||
Location |
Body (cg11351837) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.11E+00 | Statistic Test | p-value: 1.41E-04; Z-score: 1.09E+00 | ||
Methylation in Case |
8.37E-01 (Median) | Methylation in Control | 7.56E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC46A1 in colorectal cancer | [ 15 ] | |||
Location |
Body (cg04010423) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.10E+00 | Statistic Test | p-value: 8.52E-04; Z-score: 7.71E-01 | ||
Methylation in Case |
7.32E-01 (Median) | Methylation in Control | 6.66E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Systemic lupus erythematosus |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC46A1 in systemic lupus erythematosus | [ 16 ] | |||
Location |
TSS200 (cg23873654) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.04E+00 | Statistic Test | p-value: 7.58E-03; Z-score: 6.84E-02 | ||
Methylation in Case |
1.76E-02 (Median) | Methylation in Control | 1.69E-02 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus [ ICD-11: 4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC46A1 in systemic lupus erythematosus | [ 16 ] | |||
Location |
Body (cg21732977) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.16E+00 | Statistic Test | p-value: 1.03E-02; Z-score: 3.33E-01 | ||
Methylation in Case |
2.98E-02 (Median) | Methylation in Control | 2.58E-02 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus [ ICD-11: 4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC46A1 in systemic lupus erythematosus | [ 16 ] | |||
Location |
Body (cg25910803) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.00E+00 | Statistic Test | p-value: 1.82E-02; Z-score: -1.50E-01 | ||
Methylation in Case |
8.80E-01 (Median) | Methylation in Control | 8.83E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus [ ICD-11: 4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC46A1 in systemic lupus erythematosus | [ 16 ] | |||
Location |
Body (cg10762038) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 4.17E-02; Z-score: -2.21E-01 | ||
Methylation in Case |
7.92E-01 (Median) | Methylation in Control | 8.03E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus [ ICD-11: 4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Atypical teratoid rhabdoid tumor |
6 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC46A1 in atypical teratoid rhabdoid tumor | [ 17 ] | |||
Location |
1stExon (cg00497630) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.85E+00 | Statistic Test | p-value: 2.82E-34; Z-score: -5.11E+00 | ||
Methylation in Case |
4.62E-01 (Median) | Methylation in Control | 8.54E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC46A1 in atypical teratoid rhabdoid tumor | [ 17 ] | |||
Location |
1stExon (cg15612845) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.34E+00 | Statistic Test | p-value: 2.85E-18; Z-score: -3.87E+00 | ||
Methylation in Case |
7.09E-01 (Median) | Methylation in Control | 9.54E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC46A1 in atypical teratoid rhabdoid tumor | [ 17 ] | |||
Location |
1stExon (cg25014117) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.31E+00 | Statistic Test | p-value: 4.28E-16; Z-score: -2.20E+00 | ||
Methylation in Case |
6.22E-01 (Median) | Methylation in Control | 8.16E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC46A1 in atypical teratoid rhabdoid tumor | [ 17 ] | |||
Location |
Body (cg04010423) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.06E+00 | Statistic Test | p-value: 5.20E-04; Z-score: 6.30E-01 | ||
Methylation in Case |
8.91E-01 (Median) | Methylation in Control | 8.40E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC46A1 in atypical teratoid rhabdoid tumor | [ 17 ] | |||
Location |
Body (cg10762038) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.09E+00 | Statistic Test | p-value: 1.77E-02; Z-score: 2.03E-01 | ||
Methylation in Case |
1.36E-01 (Median) | Methylation in Control | 1.25E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC46A1 in atypical teratoid rhabdoid tumor | [ 17 ] | |||
Location |
Body (cg11351837) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.00E+00 | Statistic Test | p-value: 2.15E-02; Z-score: 6.18E-02 | ||
Methylation in Case |
8.99E-01 (Median) | Methylation in Control | 8.97E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
microRNA |
|||||
B-cell acute lymphoblastic leukemia |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
miR-595 downregulates SLC46A1 in B-cell acute lymphoblastic leukemia | [ 18 ] | |||
Epigenetic Type |
microRNA | Experiment Method | In-silico analysis | ||
Related Molecular Changes |
Down regulation of SLC46A1 | Experiment Method | Microarrays | ||
miRNA Stemloop ID |
miR-595 | miRNA Mature ID | miR-595 | ||
miRNA Sequence |
GAAGUGUGCCGUGGUGUGUCU | ||||
miRNA Target Type |
Direct | ||||
Studied Phenotype |
B-cell acute lymphoblastic leukemia [ ICD-11: 2A82] | ||||
Experimental Material |
Patient tissue samples | ||||
Additional Notes |
SNPs in miR-5189 that might affect SLC46A1 MTX transport gene regulation and could affect MTX levels in patients with pediatric B-cell ALL. | ||||
Epigenetic Phenomenon 2 |
miR-5189 downregulates SLC46A1 in B-cell acute lymphoblastic leukemia | [ 18 ] | |||
Epigenetic Type |
microRNA | Experiment Method | In-silico analysis | ||
miRNA Stemloop ID |
miR-5189 | miRNA Mature ID | miR-5189-5p | ||
miRNA Sequence |
UCUGGGCACAGGCGGAUGGACAGG | ||||
miRNA Target Type |
Direct | ||||
Studied Phenotype |
B-cell acute lymphoblastic leukemia [ ICD-11: 2A82] | ||||
Experimental Material |
Patient tissue samples | ||||
Additional Notes |
SNPs in miR-5189 that might affect SLC46A1 MTX transport gene regulation and could affect MTX levels in patients with pediatric B-cell ALL. | ||||
Unclear Phenotype |
31 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
miR-1238 directly targets SLC46A1 | [ 19 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-1238 | miRNA Mature ID | miR-1238-5p | ||
miRNA Sequence |
GUGAGUGGGAGCCCCAGUGUGUG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 2 |
miR-130a directly targets SLC46A1 | [ 19 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-130a | miRNA Mature ID | miR-130a-3p | ||
miRNA Sequence |
CAGUGCAAUGUUAAAAGGGCAU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 3 |
miR-130b directly targets SLC46A1 | [ 19 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-130b | miRNA Mature ID | miR-130b-3p | ||
miRNA Sequence |
CAGUGCAAUGAUGAAAGGGCAU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 4 |
miR-138-1 directly targets SLC46A1 | [ 20 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-138-1 | miRNA Mature ID | miR-138-1-3p | ||
miRNA Sequence |
GCUACUUCACAACACCAGGGCC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 5 |
miR-18a directly targets SLC46A1 | [ 21 ] | |||
Epigenetic Type |
microRNA | Experiment Method | CLASH | ||
miRNA Stemloop ID |
miR-18a | miRNA Mature ID | miR-18a-3p | ||
miRNA Sequence |
ACUGCCCUAAGUGCUCCUUCUGG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 6 |
miR-1909 directly targets SLC46A1 | [ 19 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-1909 | miRNA Mature ID | miR-1909-5p | ||
miRNA Sequence |
UGAGUGCCGGUGCCUGCCCUG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 7 |
miR-19a directly targets SLC46A1 | [ 19 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-19a | miRNA Mature ID | miR-19a-3p | ||
miRNA Sequence |
UGUGCAAAUCUAUGCAAAACUGA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 8 |
miR-19b directly targets SLC46A1 | [ 19 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-19b | miRNA Mature ID | miR-19b-3p | ||
miRNA Sequence |
UGUGCAAAUCCAUGCAAAACUGA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 9 |
miR-301a directly targets SLC46A1 | [ 19 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-301a | miRNA Mature ID | miR-301a-3p | ||
miRNA Sequence |
CAGUGCAAUAGUAUUGUCAAAGC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 10 |
miR-301b directly targets SLC46A1 | [ 19 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-301b | miRNA Mature ID | miR-301b-3p | ||
miRNA Sequence |
CAGUGCAAUGAUAUUGUCAAAGC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 11 |
miR-3666 directly targets SLC46A1 | [ 19 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-3666 | miRNA Mature ID | miR-3666 | ||
miRNA Sequence |
CAGUGCAAGUGUAGAUGCCGA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 12 |
miR-3682 directly targets SLC46A1 | [ 20 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-3682 | miRNA Mature ID | miR-3682-5p | ||
miRNA Sequence |
CUACUUCUACCUGUGUUAUCAU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 13 |
miR-4295 directly targets SLC46A1 | [ 19 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4295 | miRNA Mature ID | miR-4295 | ||
miRNA Sequence |
CAGUGCAAUGUUUUCCUU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 14 |
miR-449b directly targets SLC46A1 | [ 19 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-449b | miRNA Mature ID | miR-449b-3p | ||
miRNA Sequence |
CAGCCACAACUACCCUGCCACU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 15 |
miR-4511 directly targets SLC46A1 | [ 20 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4511 | miRNA Mature ID | miR-4511 | ||
miRNA Sequence |
GAAGAACUGUUGCAUUUGCCCU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 16 |
miR-454 directly targets SLC46A1 | [ 19 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-454 | miRNA Mature ID | miR-454-3p | ||
miRNA Sequence |
UAGUGCAAUAUUGCUUAUAGGGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 17 |
miR-4658 directly targets SLC46A1 | [ 19 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4658 | miRNA Mature ID | miR-4658 | ||
miRNA Sequence |
GUGAGUGUGGAUCCUGGAGGAAU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 18 |
miR-4713 directly targets SLC46A1 | [ 20 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4713 | miRNA Mature ID | miR-4713-5p | ||
miRNA Sequence |
UUCUCCCACUACCAGGCUCCCA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 19 |
miR-4758 directly targets SLC46A1 | [ 19 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4758 | miRNA Mature ID | miR-4758-5p | ||
miRNA Sequence |
GUGAGUGGGAGCCGGUGGGGCUG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 20 |
miR-518a directly targets SLC46A1 | [ 19 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-518a | miRNA Mature ID | miR-518a-5p | ||
miRNA Sequence |
CUGCAAAGGGAAGCCCUUUC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 21 |
miR-527 directly targets SLC46A1 | [ 19 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-527 | miRNA Mature ID | miR-527 | ||
miRNA Sequence |
CUGCAAAGGGAAGCCCUUUC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 22 |
miR-561 directly targets SLC46A1 | [ 19 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-561 | miRNA Mature ID | miR-561-3p | ||
miRNA Sequence |
CAAAGUUUAAGAUCCUUGAAGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 23 |
miR-580 directly targets SLC46A1 | [ 19 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-580 | miRNA Mature ID | miR-580-3p | ||
miRNA Sequence |
UUGAGAAUGAUGAAUCAUUAGG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 24 |
miR-629 directly targets SLC46A1 | [ 20 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-629 | miRNA Mature ID | miR-629-3p | ||
miRNA Sequence |
GUUCUCCCAACGUAAGCCCAGC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 25 |
miR-6790 directly targets SLC46A1 | [ 19 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6790 | miRNA Mature ID | miR-6790-5p | ||
miRNA Sequence |
GUGAGUGUGGAUUUGGCGGGGUU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 26 |
miR-6793 directly targets SLC46A1 | [ 20 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6793 | miRNA Mature ID | miR-6793-3p | ||
miRNA Sequence |
UCCCCAACCCCUGCCCGCAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 27 |
miR-6814 directly targets SLC46A1 | [ 20 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6814 | miRNA Mature ID | miR-6814-5p | ||
miRNA Sequence |
UCCCAAGGGUGAGAUGCUGCCA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 28 |
miR-6844 directly targets SLC46A1 | [ 19 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6844 | miRNA Mature ID | miR-6844 | ||
miRNA Sequence |
UUCUUUGUUUUUAAUUCACAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 29 |
miR-6867 directly targets SLC46A1 | [ 20 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6867 | miRNA Mature ID | miR-6867-3p | ||
miRNA Sequence |
CUCUCCCUCUUUACCCACUAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 30 |
miR-6895 directly targets SLC46A1 | [ 20 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6895 | miRNA Mature ID | miR-6895-5p | ||
miRNA Sequence |
CAGGGCCAGGCACAGAGUAAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 31 |
miR-8081 directly targets SLC46A1 | [ 19 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-8081 | miRNA Mature ID | miR-8081 | ||
miRNA Sequence |
CUUGAGUCGUGCCUUUCUGAAUG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.